胃癌内科治疗中.pptVIP

内科治疗的几个问题 Response rate as per independent review (eligible population WHO criteria) Progression-free survival Overall survival Response Rate  V 325 Phase III Interim Analysis Conclusions The REAL-2 study shows that Oxaliplatin-containing triplets have a favourablesafety profile compared with cisplatin-containing triplets Capecitabine is not inferior to PVI 5-FU Oxaliplatin is not inferior to cisplatin EOX is associated with improved efficacy vs reference ECF 内科治疗的几个问题 Stop and Go concept - OPTIMOX1 OPTIMOX Studies 内科治疗的几个问题 常见3/4度毒副反应 结 论 3度毒副反应包括中性粒细胞减少(30.8%)，白细胞减少(7.7%)，呕吐(7.